Log in to save to my catalogue

ANGPTL2 promotes immune checkpoint inhibitor-related murine autoimmune myocarditis

ANGPTL2 promotes immune checkpoint inhibitor-related murine autoimmune myocarditis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1e493d9fc86448a08d7e750b6784d837

ANGPTL2 promotes immune checkpoint inhibitor-related murine autoimmune myocarditis

About this item

Full title

ANGPTL2 promotes immune checkpoint inhibitor-related murine autoimmune myocarditis

Publisher

London: Nature Publishing Group UK

Journal title

Communications biology, 2023-09, Vol.6 (1), p.965-965, Article 965

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Use of immune checkpoint inhibitors (ICIs) as cancer immunotherapy advances rapidly in the clinic. Despite their therapeutic benefits, ICIs can cause clinically significant immune-related adverse events (irAEs), including myocarditis. However, the cellular and molecular mechanisms regulating irAE remain unclear. Here, we investigate the function of...

Alternative Titles

Full title

ANGPTL2 promotes immune checkpoint inhibitor-related murine autoimmune myocarditis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1e493d9fc86448a08d7e750b6784d837

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1e493d9fc86448a08d7e750b6784d837

Other Identifiers

ISSN

2399-3642

E-ISSN

2399-3642

DOI

10.1038/s42003-023-05338-4

How to access this item